Carmustine Accord

GIF decision: Withdrawal from market, Marketing prohibition

What does this decision mean?

  • Wycofanie z obrotu — Some of the products covered by the decision were withdrawn from the market — please return them to the pharmacy/distributor.
  • Zakaz wprowadzania — Selected batches are subject to a marketing prohibition — the product cannot be distributed to pharmacies.

The solvent component of the medicine does not meet quality requirements due to multiple exceedances of the residue after evaporation limit. Analyses indicate contamination with non-volatile residue originating from silicone tubing used for product transfer during manufacturing. Potential effects: no assurance of quality and safety of an infusion product, risk of unpredictable adverse reactions.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Carmustine Accord
Risk Level
Critical
Manufacturer
Accord Healthcare Polska Sp. z o.o.
Batch Number
M2407509, M2504302
Notice Date
03.02.2026
View official statement

Related

Other Notices